179 related articles for article (PubMed ID: 27521305)
1. Increased Hepatic Iron Content Predicts Poor Survival in Patients With Iron Overload Who Underwent Allogeneic Hematopoietic Stem Cell Transplantation.
Sivgin S; Baldane S; Deniz K; Zararsiz G; Kaynar L; Cetin M; Unal A; Eser B
Clin Lymphoma Myeloma Leuk; 2016 Aug; 16 Suppl():S10-8. PubMed ID: 27521305
[TBL] [Abstract][Full Text] [Related]
2. Increased Bone Marrow Iron Scores Are Strongly Correlated With Elevated Serum Ferritin Levels and Poorer Survival in Patients With Iron Overload That Underwent Allogeneic Hematopoietic Stem Cell Transplantation: A Single Center Experience.
Sivgin S; Nazlim S; Zararsiz G; Baspinar O; Kaynar L; Deniz K; Cetin M; Unal A; Eser B
Clin Lymphoma Myeloma Leuk; 2016 Oct; 16(10):582-587. PubMed ID: 27769559
[TBL] [Abstract][Full Text] [Related]
3. The oral iron chelator deferasirox might improve survival in allogeneic hematopoietic cell transplant (alloHSCT) recipients with transfusional iron overload.
Sivgin S; Baldane S; Akyol G; Keklik M; Kaynar L; Kurnaz F; Pala C; Zararsiz G; Cetin M; Eser B; Unal A
Transfus Apher Sci; 2013 Oct; 49(2):295-301. PubMed ID: 23916904
[TBL] [Abstract][Full Text] [Related]
4. Pretransplant serum ferritin level may be a predictive marker for outcomes in patients having undergone allogeneic hematopoietic stem cell transplantation.
Sivgin S; Baldane S; Kaynar L; Kurnaz F; Pala C; Ozturk A; Cetin M; Unal A; Eser B
Neoplasma; 2012; 59(2):183-90. PubMed ID: 22248276
[TBL] [Abstract][Full Text] [Related]
5. Iron overload in allogeneic hematopoietic stem cell transplant recipients.
Ali S; Pimentel JD; Munoz J; Shah V; McKinnon R; Divine G; Janakiraman N
Arch Pathol Lab Med; 2012 May; 136(5):532-8. PubMed ID: 22540302
[TBL] [Abstract][Full Text] [Related]
6. Iron overload manifesting as apparent exacerbation of hepatic graft-versus-host disease after allogeneic hematopoietic stem cell transplantation.
Kamble RT; Selby GB; Mims M; Kharfan-Dabaja MA; Ozer H; George JN
Biol Blood Marrow Transplant; 2006 May; 12(5):506-10. PubMed ID: 16635785
[TBL] [Abstract][Full Text] [Related]
7. Association of iron overload with allogeneic hematopoietic cell transplantation outcomes: a prospective cohort study using R2-MRI-measured liver iron content.
Trottier BJ; Burns LJ; DeFor TE; Cooley S; Majhail NS
Blood; 2013 Aug; 122(9):1678-84. PubMed ID: 23777771
[TBL] [Abstract][Full Text] [Related]
8. The Prognostic Significance of Elevated Serum Ferritin Levels Prior to Transplantation in Patients With Lymphoma Who Underwent Autologous Hematopoietic Stem Cell Transplantation (autoHSCT): Role of Iron Overload.
Sivgin S; Karamustafaoglu MF; Yildizhan E; Zararsiz G; Kaynar L; Eser B; Cetin M; Unal A
Clin Lymphoma Myeloma Leuk; 2016 Aug; 16 Suppl():S152-8. PubMed ID: 27521313
[TBL] [Abstract][Full Text] [Related]
9. Prognostic impact of posttransplantation iron overload after allogeneic stem cell transplantation.
Meyer SC; O'Meara A; Buser AS; Tichelli A; Passweg JR; Stern M
Biol Blood Marrow Transplant; 2013 Mar; 19(3):440-4. PubMed ID: 23089566
[TBL] [Abstract][Full Text] [Related]
10. Measurement of liver iron concentration by superconducting quantum interference device biomagnetic liver susceptometry validates serum ferritin as prognostic parameter for allogeneic stem cell transplantation.
Jacobi N; Herich L
Eur J Haematol; 2016 Oct; 97(4):336-41. PubMed ID: 26800433
[TBL] [Abstract][Full Text] [Related]
11. Iron overload in patients receiving allogeneic hematopoietic stem cell transplantation: quantification of iron burden by a superconducting quantum interference device (SQUID) and therapeutic effectiveness of phlebotomy.
Busca A; Falda M; Manzini P; D'Antico S; Valfrè A; Locatelli F; Calabrese R; Chiappella A; D'Ardia S; Longo F; Piga A
Biol Blood Marrow Transplant; 2010 Jan; 16(1):115-22. PubMed ID: 19766730
[TBL] [Abstract][Full Text] [Related]
12. [Liver biopsy in the management of liver dysfunction after allogeneic hematopoietic stem-cell transplantation].
Chen H; Huang XJ; Liu KY; Xu LP; Wang H; Liu DH; Lu J; Lu DP
Zhonghua Yi Xue Za Zhi; 2005 Nov; 85(43):3062-6. PubMed ID: 16324408
[TBL] [Abstract][Full Text] [Related]
13. Association between Plasma Endothelin-1, Transforming Growth Factor-β, Fibroblast Growth Factor, and Nitric Oxide Levels and Liver Injury in Hematopoietic Stem Cell Transplantation Recipients with Persistent Iron Overload after Transplantation.
Akı ŞZ; Suyanı E; Cengiz M; Özenirler S; Elbeğ Ş; Paşaoğlu H; Sucak GT
Biol Blood Marrow Transplant; 2015 May; 21(5):948-53. PubMed ID: 25681034
[TBL] [Abstract][Full Text] [Related]
14. Compound heterozygosity for haemochromatosis gene mutations and hepatic iron overload in allogeneic bone marrow transplant recipients.
Grigg AP; Bhathal PS
Pathology; 2001 Feb; 33(1):44-9. PubMed ID: 11280607
[TBL] [Abstract][Full Text] [Related]
15. Pretransplant iron overload may be associated with increased risk of invasive fungal pneumonia (IFP) in patients that underwent allogeneic hematopoietic stem cell transplantation (alloHSCT).
Sivgin S; Baldane S; Kaynar L; Kurnaz F; Pala C; Sivgin H; Keklik M; Demiraslan H; Cetin M; Eser B; Unal A
Transfus Apher Sci; 2013 Feb; 48(1):103-8. PubMed ID: 22985533
[TBL] [Abstract][Full Text] [Related]
16. A prospective study of iron overload management in allogeneic hematopoietic cell transplantation survivors.
Majhail NS; Lazarus HM; Burns LJ
Biol Blood Marrow Transplant; 2010 Jun; 16(6):832-7. PubMed ID: 20079863
[TBL] [Abstract][Full Text] [Related]
17. High prevalence of iron overload in adult allogeneic hematopoietic cell transplant survivors.
Majhail NS; DeFor T; Lazarus HM; Burns LJ
Biol Blood Marrow Transplant; 2008 Jul; 14(7):790-4. PubMed ID: 18541198
[TBL] [Abstract][Full Text] [Related]
18. Efficacy and safety of oral deferasirox treatment in the posttransplant period for patients who have undergone allogeneic hematopoietic stem cell transplantation (alloHSCT).
Sivgin S; Eser B; Bahcebasi S; Kaynar L; Kurnaz F; Uzer E; Pala C; Deniz K; Ozturk A; Cetin M; Unal A
Ann Hematol; 2012 May; 91(5):743-749. PubMed ID: 22051904
[TBL] [Abstract][Full Text] [Related]
19. The management of iron overload in allogeneic hematopoietic stem cell transplant (alloHSCT) recipients: where do we stand?
Sivgin S; Eser B
Ann Hematol; 2013 May; 92(5):577-86. PubMed ID: 23430087
[TBL] [Abstract][Full Text] [Related]
20. The role of liver biopsy in the workup of liver dysfunction late after SCT: is the role of iron overload underestimated?
Sucak GT; Yegin ZA; Ozkurt ZN; Aki SZ; Karakan T; Akyol G
Bone Marrow Transplant; 2008 Oct; 42(7):461-7. PubMed ID: 18604240
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
